Want to see HK:0314 full AI Analyst Report?
0314 Stock Chart & Stats
HK$2.48
HK$0.09(1.75%)
At close: 4:00 PM EST
HK$2.48
HK$0.09(1.75%)
Day’s Range― - ―
52-Week RangeHK$1.13 - HK$5.51
Previous CloseN/A
Volume1.18M
Average Volume (3M)2.05M
Market Cap
HK$891.38M
Enterprise Value-HK$105.97
Total Cash (Recent Filing)HK$597.85M
Total Debt (Recent Filing)HK$24.70M
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding765,773,900
10 Day Avg. Volume1,436,880
30 Day Avg. Volume2,048,921
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.44
Price to Sales (P/S)0.67
P/FCF Ratio10.60K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.04
Revenue Forecast (FY)HK$1.92B
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageVery low recent leverage and positive equity reduce refinancing risk and preserve financial flexibility. This gives the company greater capacity to manage operating volatility or fund a recovery without relying heavily on additional debt.
Improving Gross MarginImproved gross margin and narrower losses indicate potential benefits from cost actions or a better business mix. If maintained, this can strengthen unit economics and provide operating leverage when revenue conditions stabilize.
Operating Cash Flow InflectionThe move to positive operating cash flow is an encouraging sign that working-capital or operating improvements may be taking hold. Sustaining this change would reduce dependence on external funding and improve financial resilience.
Bears Say
Sharp Revenue ContractionA steep revenue decline weakens scale, limits operating leverage, and makes a return to profitability more difficult. Persistent contraction could also reduce bargaining power and constrain investment in distribution capabilities and growth initiatives.
Persistent UnprofitabilityContinued operating and net losses show that the business has not yet established a sustainable profit model. Ongoing losses can erode equity, restrict strategic investment, and leave earnings recovery dependent on a significant improvement in demand or margins.
Fragile Free Cash FlowDespite the positive operating cash flow inflection, free cash flow remains too weak to demonstrate durable self-funding. Prior negative cash generation indicates limited capacity to absorb shocks, invest consistently, or support growth without external capital.
Sipai Health Technology Co., Ltd. News
0314 FAQ
What was Sipai Health Technology Co., Ltd.’s price range in the past 12 months?
Sipai Health Technology Co., Ltd. lowest stock price was HK$1.13 and its highest was HK$5.51 in the past 12 months.
What is Sipai Health Technology Co., Ltd.’s market cap?
Sipai Health Technology Co., Ltd.’s market cap is HK$891.38M.
When is Sipai Health Technology Co., Ltd.’s upcoming earnings report date?
Sipai Health Technology Co., Ltd.’s upcoming earnings report date is Mar 23, 2027 which is in 207 days.
How were Sipai Health Technology Co., Ltd.’s earnings last quarter?
Sipai Health Technology Co., Ltd. released its earnings results on Aug 20, 2026. The company reported HK$0.082 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Sipai Health Technology Co., Ltd. overvalued?
According to Wall Street analysts Sipai Health Technology Co., Ltd.’s price is currently Overvalued.
Does Sipai Health Technology Co., Ltd. pay dividends?
Sipai Health Technology Co., Ltd. does not currently pay dividends.
What is Sipai Health Technology Co., Ltd.’s EPS estimate?
Sipai Health Technology Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sipai Health Technology Co., Ltd. have?
Sipai Health Technology Co., Ltd. has 765,773,900 shares outstanding.
What happened to Sipai Health Technology Co., Ltd.’s price movement after its last earnings report?
Sipai Health Technology Co., Ltd. reported an EPS of HK$0.082 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.397%.
Which hedge fund is a major shareholder of Sipai Health Technology Co., Ltd.?
Currently, no hedge funds are holding shares in HK:0314
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sipai Health Technology Co., Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.48%
Trailing 12-Months
Company Description
Sipai Health Technology Co., Ltd.
Sipai Health Technology Co., Ltd. is a Chinese enterprise specializing in medical technology and health management. Its business operations are diversified across three primary divisions: Specialty Pharmacy, Physician Research Assistance, and Health Insurance Services. The Specialty Pharmacy division manages a network of dedicated pharmacies and is also involved in the distribution of pharmaceutical products to drug manufacturers and other supply chain partners. Through its Physician Research Assistance segment, Sipai Health provides comprehensive site management organization (SMO) support to pharmaceutical firms and clinical research institutions. These services encompass a broad spectrum, including site identification and setup, patient acquisition and oversight, data and document handling, on-site logistical management of drugs and biosamples, and trial conclusion. Additionally, this segment offers specialized image management for clinical studies. The Health Insurance Services division functions as an intermediary, delivering brokerage solutions to various insurance providers. Established in 2014, the company's headquarters are situated in Guangzhou, China.
Technical Analysis
Dingdang Health Technology Group Ltd.
―
EC Healthcare
―
Mediwelcome Healthcare Management & Technology Inc.
―
Beijing Airdoc Technology Co. Ltd. Class H
―
NEUSOFT XIKANG HOLDINGS INC.
―